Department of General, Visceral, Transplantation, Vascular and Thoracic Surgery, Hospital of the Ludwig Maximilian University , Munich , Germany.
Institute of Medical Statistics and Epidemiology, Klinikum Rechts der Isar, Technical University , Munich , Germany.
BMJ Open Respir Res. 2015 Jul 15;2(1):e000090. doi: 10.1136/bmjresp-2015-000090. eCollection 2015.
Preoperative bronchoscopic tumour ablation has been suggested as a beneficial treatment for bronchopulmonary carcinoid tumours, although data regarding its effects and long-term outcome are lacking.
In our case-matched cohort study with 208 patients with bronchopulmonary carcinoid tumours we investigated the role of preoperative bronchoscopic interventions before subsequent surgery and analysed the safety of this Procedure of Endobronchial Preparation for Parenchyma-sparing Surgery (PEPPS) based on metastasis and recurrence rates as well as survival data from 1991 to 2010. The subsequent surgery was classified into parenchyma-sparing procedures and classical lobectomies, bilobectomies and pneumonectomies. Data were obtained from the tumour registry and medical reports. Outcomes were the frequency of parenchyma-sparing surgery after bronchoscopic treatment as well as rates of metastasis, recurrence and survival.
132 of 208 carcinoids were located centrally. Among them, 77 patients could be recanalised preoperatively. After bronchoscopic preparation, the rate of subsequent parenchyma-sparing surgery methods was higher (p=0.021). The effect was measured by the number of segments removed. The 10-year survival rate was 89% (typical carcinoids) and 68% (atypical carcinoids), respectively. After applying PEPPS, long-term survival was slightly higher (p=0.23). Metastasis and recurrence rates showed no relevant differences between the bronchoscopically treated or non-treated groups, or between the two types of surgery classes or between the PEPPS and non-PEPPS groups.
After preoperative bronchoscopic treatment, parenchyma-sparing surgery techniques can be applied more frequently. Furthermore, we detected no negative effects after PEPPS based on metastasis, recurrence and survival rates.
术前支气管镜下肿瘤消融术被认为是治疗支气管肺类癌肿瘤的有益方法,但缺乏关于其效果和长期结果的数据。
在我们的 208 例支气管肺类癌肿瘤患者的病例匹配队列研究中,我们研究了术前支气管镜介入在随后的手术中的作用,并根据从 1991 年到 2010 年的转移和复发率以及生存数据分析了这种经支气管准备术(PEPPS)的安全性,用于保留肺实质的手术。随后的手术分为保留肺实质的手术和经典的肺叶切除术、双肺叶切除术和全肺切除术。数据来自肿瘤登记处和医疗报告。结果是支气管镜治疗后保留肺实质手术的频率以及转移、复发和生存的发生率。
208 例类癌中有 132 例位于中央。其中,77 例患者可在术前再通。支气管镜准备后,后续保留肺实质的手术方法的比例更高(p=0.021)。效果通过切除的节段数来衡量。10 年的生存率分别为 89%(典型类癌)和 68%(非典型类癌)。应用 PEPPS 后,长期生存率略高(p=0.23)。转移和复发率在支气管镜治疗组和非治疗组之间、两种手术类型之间或 PEPPS 组和非 PEPPS 组之间没有明显差异。
术前支气管镜治疗后,可更频繁地应用保留肺实质的手术技术。此外,根据转移、复发和生存率,我们未发现 PEPPS 后有任何负面影响。